Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-6-19
pubmed:abstractText
DRF 8417, a novel oxazolidinone, has been evaluated against Gram-positive and fastidious Gram-negative bacteria. In vitro activity of DRF 8417 was determined by broth microdilution method and in vivo efficacy studies were carried out in different murine systemic infection models.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0305-7453
pubmed:author
pubmed:issnType
Print
pubmed:volume
60
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
159-61
pubmed:meshHeading
pubmed-meshheading:17449889-Animals, pubmed-meshheading:17449889-Anti-Infective Agents, pubmed-meshheading:17449889-Disease Models, Animal, pubmed-meshheading:17449889-Female, pubmed-meshheading:17449889-Gram-Negative Bacterial Infections, pubmed-meshheading:17449889-Gram-Positive Bacterial Infections, pubmed-meshheading:17449889-Gram-Positive Cocci, pubmed-meshheading:17449889-Haemophilus Infections, pubmed-meshheading:17449889-Haemophilus influenzae, pubmed-meshheading:17449889-Humans, pubmed-meshheading:17449889-Male, pubmed-meshheading:17449889-Mice, pubmed-meshheading:17449889-Microbial Sensitivity Tests, pubmed-meshheading:17449889-Moraxella (Branhamella) catarrhalis, pubmed-meshheading:17449889-Moraxellaceae Infections, pubmed-meshheading:17449889-Oxazolidinones, pubmed-meshheading:17449889-Specific Pathogen-Free Organisms, pubmed-meshheading:17449889-Treatment Outcome, pubmed-meshheading:17449889-beta-Lactam Resistance, pubmed-meshheading:17449889-beta-Lactamases
pubmed:year
2007
pubmed:articleTitle
In vitro and in vivo antibacterial evaluation of DRF 8417, a new oxazolidinone.
pubmed:affiliation
Anti-infective Group, Discovery Research, Dr Reddy's Laboratories Ltd, Miyapur, Hyderabad 500 049, India. sreenivaskandepu@drreddys.com
pubmed:publicationType
Journal Article